Cells derived from iPSC can be immunogenic -- Yes or No

The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without...

Full description

Saved in:
Bibliographic Details
Published inProtein & cell Vol. 5; no. 1; pp. 1 - 3
Main Authors Cao, Jiani, Li, Xiaoyan, Lu, Xiao, Zhang, Chao, Yu, Honghao, Zhao, Tongbiao
Format Journal Article
LanguageEnglish
Published Beijing Higher Education Press 2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syn- geneic iPSC-derived cells can be immunogenic in syn- geneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ lay- ers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negli- gible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergenUy required for translation of iPSC technology to clinics.
AbstractList The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negligible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics.The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negligible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics.
The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negligible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics.
The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syn- geneic iPSC-derived cells can be immunogenic in syn- geneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ lay- ers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negli- gible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergenUy required for translation of iPSC technology to clinics.
The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212–215, 2011 ). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either “negligible” or “lack of” immunogenicity in iPSC derivatives (Nature 494:100–104, 2013 ; Cell Stem Cell 12:407–412, 2013 ). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics.
Author Lu, Xiao
Cao, Jiani
Yu, Honghao
Zhang, Chao
Zhao, Tongbiao
Li, Xiaoyan
AuthorAffiliation State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
Author_xml – sequence: 1
  givenname: Jiani
  surname: Cao
  fullname: Cao, Jiani
  organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
– sequence: 2
  givenname: Xiaoyan
  surname: Li
  fullname: Li, Xiaoyan
  organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
– sequence: 3
  givenname: Xiao
  surname: Lu
  fullname: Lu, Xiao
  organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
– sequence: 4
  givenname: Chao
  surname: Zhang
  fullname: Zhang, Chao
  organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
– sequence: 5
  givenname: Honghao
  surname: Yu
  fullname: Yu, Honghao
  organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
– sequence: 6
  givenname: Tongbiao
  surname: Zhao
  fullname: Zhao, Tongbiao
  email: tbzhao@ioz.ac.cn
  organization: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24474200$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAUtFArWkp_ABdkblxC_ZXYuSChVfmQqoIESHCyHOc56yqxt3ZSiX9Poiwr6GE52ZJn5s288TN0EmIAhF5Q8oYSIq8y5YyrglBeEEJ4wZ6gc1pJUShC1cnhTn6cocuc78gC4rSs5FN0xoSQghFyjuQG-j7jFpJ_gBa7FAfsv3zdYGsCbgD7YZhC7CB4i4sC_4SMY8K38Tk6dabPcLk_L9D399ffNh-Lm88fPm3e3RS2LMlYVE1d8dopKSvFG-WqVpDKSVUa1oi2JkI2glFWOccdt61UDQPbWqO44k6Qhl-gt6vubmoGaC2EMZle75IfTPqlo_H635fgt7qLD5rXXKmSzQKv9wIp3k-QRz34bOfQJkCcsqZSVKqWoi7_Dy2JoCUt2QJ9-betg58_i50BdAXYFHNO4A4QSvTSn17703N_eqlGL1blI471oxl9XJL5_iiTrcw8TwkdJH0XpxTmYo6S1Era-m4LCdpdgpz1_AXC6CEdp77aO93G0N3PIw_xRE1rTjnnvwEQ4siw
CitedBy_id crossref_primary_10_1016_j_cjca_2014_06_023
crossref_primary_10_2217_fca_2016_0071
crossref_primary_10_3390_cells11030529
crossref_primary_10_4252_wjsc_v15_i5_453
crossref_primary_10_1101_cshperspect_a029561
crossref_primary_10_1007_s11427_016_0114_9
crossref_primary_10_3390_ijms22020958
crossref_primary_10_1038_celldisc_2015_15
crossref_primary_10_1186_s12938_019_0691_9
crossref_primary_10_4103_1673_5374_150638
crossref_primary_10_3389_fimmu_2014_00439
crossref_primary_10_1160_TH14_05_0480
crossref_primary_10_1007_s10741_016_9576_1
crossref_primary_10_3233_BPL_170055
crossref_primary_10_1111_imm_12722
crossref_primary_10_3390_ijms21093077
crossref_primary_10_1134_S1990747816010074
crossref_primary_10_1096_fj_202402790R
crossref_primary_10_1186_s13287_015_0167_1
crossref_primary_10_1016_j_addr_2015_06_005
crossref_primary_10_1002_stem_2752
crossref_primary_10_3402_arb_v2_27144
crossref_primary_10_1038_s41536_021_00183_7
crossref_primary_10_1371_journal_pone_0106110
crossref_primary_10_1038_srep29955
crossref_primary_10_1038_cdd_2017_90
crossref_primary_10_3390_ijms21124384
crossref_primary_10_1007_s00441_019_03161_0
crossref_primary_10_1038_cddis_2014_205
crossref_primary_10_1186_s13287_022_03181_8
crossref_primary_10_1007_s00005_016_0385_y
crossref_primary_10_3390_cells13121045
crossref_primary_10_1016_j_cellimm_2018_03_006
crossref_primary_10_4137_BMI_S20313
crossref_primary_10_1002_JLB_5BT0420_585RR
crossref_primary_10_1007_s11892_017_0901_4
crossref_primary_10_1007_s12015_017_9790_9
crossref_primary_10_1186_s13045_014_0050_z
crossref_primary_10_1002_med_21839
crossref_primary_10_1089_scd_2014_0151
Cites_doi 10.1093/ajcp/82.1.115
10.1038/nature09798
10.1634/stemcells.2007-0151
10.1038/ng.471
10.1038/nbt.1667
10.1038/nature10135
10.1016/j.tcb.2009.12.004
10.1038/nature09342
10.1038/nature11807
10.1016/j.stem.2013.01.006
10.1097/00000658-198309000-00016
10.1016/j.cell.2006.07.024
10.1038/nature09805
ContentType Journal Article
Copyright Copyright reserved, 2014, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The Author(s) 2014
Copyright_xml – notice: Copyright reserved, 2014, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: The Author(s) 2014
DBID 2RA
92L
CQIGP
~WA
C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
5PM
DOI 10.1007/s13238-013-0003-2
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库- 镜像站点
Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts




MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Cells derived from iPSC can be immunogenic -- Yes or No
EISSN 1674-8018
EndPage 3
ExternalDocumentID PMC3938852
24474200
10_1007_s13238_013_0003_2
10.1007/s13238-013-0003-2
49193133
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-A0
0R~
0VY
1-T
1N0
2JY
2RA
2VQ
30V
3V.
408
409
40D
53G
5VS
67N
7X7
88E
8AO
8FE
8FH
8FI
8FJ
92L
AAFWJ
AAKKN
AAPXW
AAVAP
AAYZJ
ABPTD
ABUWG
ACACY
ACGFS
ACPRK
ADBBV
ADINQ
AENEX
AFGXO
AFKRA
AFNRJ
AFPKN
AFWTZ
AGJBK
AHBXF
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
C24
C6C
CAG
CCPQU
COF
CQIGP
DIK
EBD
EBS
EMOBN
F5P
FYUFA
GQ8
GROUPED_DOAJ
HCIFZ
HMCUK
HMJXF
HYE
HZ~
I0C
IPNFZ
IZIGR
KOV
KQ8
LK8
M1P
M4Y
M7P
NU0
O9-
OJZSN
OK1
P4S
PIMPY
PQQKQ
PROAC
PSQYO
QOS
R9I
RIG
ROX
RPM
RSV
S27
S3A
S3B
SBL
SCL
SOJ
SV3
T13
TOX
TUS
U2A
UKHRP
WK8
~A9
~WA
ABXVV
ACULB
AAYZH
ABEEZ
ABEJV
ABGNP
ALIPV
AMNDL
H13
-SA
-S~
AAXDM
AAYXX
ABFSG
ACSTC
AEZWR
AFHIU
AHWEU
AIXLP
CAJEA
CITATION
PHGZM
PHGZT
Q--
TGP
U1G
U5K
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7X8
7T5
H94
5PM
ID FETCH-LOGICAL-c550t-6b9639f877683b8f6d406f785a2b4d9047b42126ff3f3cd78b2ecdca8383f40b3
IEDL.DBID C6C
ISSN 1674-800X
1674-8018
IngestDate Thu Aug 21 18:25:50 EDT 2025
Fri Jul 11 05:31:28 EDT 2025
Mon Jul 21 10:35:15 EDT 2025
Mon Jul 21 06:05:26 EDT 2025
Tue Jul 01 03:08:02 EDT 2025
Thu Apr 24 22:56:17 EDT 2025
Fri Feb 21 02:33:12 EST 2025
Tue Feb 27 04:43:01 EST 2024
Wed Feb 14 10:37:30 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Immune Rejection
Pluripotent Stem Cell
Teratoma
Autologous Cell
iPSC
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
http://www.springer.com/tdm
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c550t-6b9639f877683b8f6d406f785a2b4d9047b42126ff3f3cd78b2ecdca8383f40b3
Notes The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syn- geneic iPSC-derived cells can be immunogenic in syn- geneic hosts by using a teratoma transplantation model (Nature 474:212-215, 2011). Recently two research groups differentiated the iPSCs into different germ lay- ers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either "negli- gible" or "lack of" immunogenicity in iPSC derivatives (Nature 494:100-104, 2013; Cell Stem Cell 12:407-412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergenUy required for translation of iPSC technology to clinics.
11-5886/Q
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1007/s13238-013-0003-2
PMID 24474200
PQID 1504151525
PQPubID 23479
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3938852
proquest_miscellaneous_1746897495
proquest_miscellaneous_1504151525
pubmed_primary_24474200
crossref_primary_10_1007_s13238_013_0003_2
crossref_citationtrail_10_1007_s13238_013_0003_2
springer_journals_10_1007_s13238_013_0003_2
higheredpress_frontiers_10_1007_s13238_013_0003_2
chongqing_primary_49193133
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014
20140100
2014-1-00
2014-Jan
20140101
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014
PublicationDecade 2010
PublicationPlace Beijing
PublicationPlace_xml – name: Beijing
– name: Germany
PublicationTitle Protein & cell
PublicationTitleAbbrev Protein Cell
PublicationTitleAlternate Protein & Cell
PublicationYear 2014
Publisher Higher Education Press
Publisher_xml – name: Higher Education Press
References GoreALiZFungHLYoungJEAgarwalSNature2011471636710.1038/nature098051:CAS:528:DC%2BC3MXis1CrsLg%3D, 3074107, 21368825, 10.1038/nature09805
TapperDLackEEAnn Surg198319839841010.1097/00000658-198309000-000161:STN:280:DyaL3szgslKhsA%3D%3D, 1353316, 6684416, 10.1097/00000658-198309000-00016
ListerRPelizzolaMKidaYSHawkinsRDNeryJRNature2011471687310.1038/nature097981:CAS:528:DC%2BC3MXhsVWjt78%3D, 3100360, 21289626, 10.1038/nature09798
KochCAGeraldesPPlattJLStem Cells200826899810.1634/stemcells.2007-01511:CAS:528:DC%2BD1cXhvVCktL4%3D, 17962705, 10.1634/stemcells.2007-0151
ArakiRUdaMHokiYSunayamaMNakamuraMNature201349410010410.1038/nature118071:CAS:528:DC%2BC3sXhtFSnt70%3D, 23302801, 10.1038/nature11807
TakahashiKYamanakaSCell200612666367610.1016/j.cell.2006.07.0241:CAS:528:DC%2BD28Xpt1aktbs%3D, 16904174, 10.1016/j.cell.2006.07.024
ChiJGLeeYSParkYSChangKYAm J Clin Pathol1984821151191:STN:280:DyaL2c3ltlKhsA%3D%3D, 6540049
ZhaoTZhangZNRongZXuYNature201147421221510.1038/nature101351:CAS:528:DC%2BC3MXntFKktLo%3D, 21572395, 10.1038/nature10135
PoloJMLiuSFigueroaMEKulalertWEminliSNat Biotechnol20102884885510.1038/nbt.16671:CAS:528:DC%2BC3cXovFOns7c%3D, 3148605, 20644536, 10.1038/nbt.1667
KimKDoiAWenBNgKZhaoRNature201046728529010.1038/nature093421:CAS:528:DC%2BC3cXhtFOht7rJ, 3150836, 20644535, 10.1038/nature09342
ZhaoTXuYTrends Cell Biol20102017017510.1016/j.tcb.2009.12.0041:CAS:528:DC%2BC3cXisFemu7o%3D, 20061153, 10.1016/j.tcb.2009.12.004
DoiAParkIHWenBMurakamiPAryeeMJNat Genet2009411350135310.1038/ng.4711:CAS:528:DC%2BD1MXhtlers7rM, 2958040, 19881528, 10.1038/ng.471
GuhaPMorganJWMostoslavskyGRodriguesNPBoydASCell Stem Cell20131240741210.1016/j.stem.2013.01.0061:CAS:528:DC%2BC3sXhsFGjsbw%3D, 23352605, 10.1016/j.stem.2013.01.006
D Tapper (3_CR11) 1983; 198
CA Koch (3_CR7) 2008; 26
K Takahashi (3_CR10) 2006; 126
K Kim (3_CR6) 2010; 467
R Lister (3_CR8) 2011; 471
P Guha (3_CR5) 2013; 12
T Zhao (3_CR12) 2010; 20
A Gore (3_CR4) 2011; 471
JG Chi (3_CR2) 1984; 82
JM Polo (3_CR9) 2010; 28
R Araki (3_CR1) 2013; 494
T Zhao (3_CR13) 2011; 474
A Doi (3_CR3) 2009; 41
20644536 - Nat Biotechnol. 2010 Aug;28(8):848-55
20061153 - Trends Cell Biol. 2010 Mar;20(3):170-5
19881528 - Nat Genet. 2009 Dec;41(12):1350-3
23302801 - Nature. 2013 Feb 7;494(7435):100-4
23352605 - Cell Stem Cell. 2013 Apr 4;12(4):407-12
20644535 - Nature. 2010 Sep 16;467(7313):285-90
17962705 - Stem Cells. 2008 Jan;26(1):89-98
21368825 - Nature. 2011 Mar 3;471(7336):63-7
21289626 - Nature. 2011 Mar 3;471(7336):68-73
21572395 - Nature. 2011 Jun 9;474(7350):212-5
16904174 - Cell. 2006 Aug 25;126(4):663-76
6684416 - Ann Surg. 1983 Sep;198(3):398-410
6540049 - Am J Clin Pathol. 1984 Jul;82(1):115-9
References_xml – reference: ChiJGLeeYSParkYSChangKYAm J Clin Pathol1984821151191:STN:280:DyaL2c3ltlKhsA%3D%3D, 6540049
– reference: TakahashiKYamanakaSCell200612666367610.1016/j.cell.2006.07.0241:CAS:528:DC%2BD28Xpt1aktbs%3D, 16904174, 10.1016/j.cell.2006.07.024
– reference: ZhaoTZhangZNRongZXuYNature201147421221510.1038/nature101351:CAS:528:DC%2BC3MXntFKktLo%3D, 21572395, 10.1038/nature10135
– reference: ArakiRUdaMHokiYSunayamaMNakamuraMNature201349410010410.1038/nature118071:CAS:528:DC%2BC3sXhtFSnt70%3D, 23302801, 10.1038/nature11807
– reference: DoiAParkIHWenBMurakamiPAryeeMJNat Genet2009411350135310.1038/ng.4711:CAS:528:DC%2BD1MXhtlers7rM, 2958040, 19881528, 10.1038/ng.471
– reference: GoreALiZFungHLYoungJEAgarwalSNature2011471636710.1038/nature098051:CAS:528:DC%2BC3MXis1CrsLg%3D, 3074107, 21368825, 10.1038/nature09805
– reference: GuhaPMorganJWMostoslavskyGRodriguesNPBoydASCell Stem Cell20131240741210.1016/j.stem.2013.01.0061:CAS:528:DC%2BC3sXhsFGjsbw%3D, 23352605, 10.1016/j.stem.2013.01.006
– reference: ZhaoTXuYTrends Cell Biol20102017017510.1016/j.tcb.2009.12.0041:CAS:528:DC%2BC3cXisFemu7o%3D, 20061153, 10.1016/j.tcb.2009.12.004
– reference: KochCAGeraldesPPlattJLStem Cells200826899810.1634/stemcells.2007-01511:CAS:528:DC%2BD1cXhvVCktL4%3D, 17962705, 10.1634/stemcells.2007-0151
– reference: ListerRPelizzolaMKidaYSHawkinsRDNeryJRNature2011471687310.1038/nature097981:CAS:528:DC%2BC3MXhsVWjt78%3D, 3100360, 21289626, 10.1038/nature09798
– reference: TapperDLackEEAnn Surg198319839841010.1097/00000658-198309000-000161:STN:280:DyaL3szgslKhsA%3D%3D, 1353316, 6684416, 10.1097/00000658-198309000-00016
– reference: KimKDoiAWenBNgKZhaoRNature201046728529010.1038/nature093421:CAS:528:DC%2BC3cXhtFOht7rJ, 3150836, 20644535, 10.1038/nature09342
– reference: PoloJMLiuSFigueroaMEKulalertWEminliSNat Biotechnol20102884885510.1038/nbt.16671:CAS:528:DC%2BC3cXovFOns7c%3D, 3148605, 20644536, 10.1038/nbt.1667
– volume: 82
  start-page: 115
  year: 1984
  ident: 3_CR2
  publication-title: Am J Clin Pathol
  doi: 10.1093/ajcp/82.1.115
– volume: 471
  start-page: 68
  year: 2011
  ident: 3_CR8
  publication-title: Nature
  doi: 10.1038/nature09798
– volume: 26
  start-page: 89
  year: 2008
  ident: 3_CR7
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2007-0151
– volume: 41
  start-page: 1350
  year: 2009
  ident: 3_CR3
  publication-title: Nat Genet
  doi: 10.1038/ng.471
– volume: 28
  start-page: 848
  year: 2010
  ident: 3_CR9
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.1667
– volume: 474
  start-page: 212
  year: 2011
  ident: 3_CR13
  publication-title: Nature
  doi: 10.1038/nature10135
– volume: 20
  start-page: 170
  year: 2010
  ident: 3_CR12
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2009.12.004
– volume: 467
  start-page: 285
  year: 2010
  ident: 3_CR6
  publication-title: Nature
  doi: 10.1038/nature09342
– volume: 494
  start-page: 100
  year: 2013
  ident: 3_CR1
  publication-title: Nature
  doi: 10.1038/nature11807
– volume: 12
  start-page: 407
  year: 2013
  ident: 3_CR5
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.01.006
– volume: 198
  start-page: 398
  year: 1983
  ident: 3_CR11
  publication-title: Ann Surg
  doi: 10.1097/00000658-198309000-00016
– volume: 126
  start-page: 663
  year: 2006
  ident: 3_CR10
  publication-title: Cell
  doi: 10.1016/j.cell.2006.07.024
– volume: 471
  start-page: 63
  year: 2011
  ident: 3_CR4
  publication-title: Nature
  doi: 10.1038/nature09805
– reference: 20061153 - Trends Cell Biol. 2010 Mar;20(3):170-5
– reference: 16904174 - Cell. 2006 Aug 25;126(4):663-76
– reference: 20644536 - Nat Biotechnol. 2010 Aug;28(8):848-55
– reference: 6684416 - Ann Surg. 1983 Sep;198(3):398-410
– reference: 21289626 - Nature. 2011 Mar 3;471(7336):68-73
– reference: 23302801 - Nature. 2013 Feb 7;494(7435):100-4
– reference: 23352605 - Cell Stem Cell. 2013 Apr 4;12(4):407-12
– reference: 21368825 - Nature. 2011 Mar 3;471(7336):63-7
– reference: 6540049 - Am J Clin Pathol. 1984 Jul;82(1):115-9
– reference: 20644535 - Nature. 2010 Sep 16;467(7313):285-90
– reference: 19881528 - Nat Genet. 2009 Dec;41(12):1350-3
– reference: 17962705 - Stem Cells. 2008 Jan;26(1):89-98
– reference: 21572395 - Nature. 2011 Jun 9;474(7350):212-5
SSID ssj0000331567
Score 2.1960838
Snippet The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited...
The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
higheredpress
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Animals
Biochemistry
Biomedical and Life Sciences
Cell Biology
Cell Cycle Proteins - metabolism
Cell Transplantation - methods
Developmental Biology
Discussion
Graft Rejection - immunology
Human Genetics
Induced Pluripotent Stem Cells - immunology
Induced Pluripotent Stem Cells - transplantation
iPS
Life Sciences
Membrane Proteins - metabolism
Mice, Knockout
Protein Science
Stem Cells
Teratoma - immunology
Teratoma - metabolism
体细胞
免疫原性
免疫排斥反应
免疫耐受
再生医学
多能干细胞
细胞分化
Title Cells derived from iPSC can be immunogenic -- Yes or No
URI http://lib.cqvip.com/qk/71234X/201401/49193133.html
https://journal.hep.com.cn/pac/EN/10.1007/s13238-013-0003-2
https://link.springer.com/article/10.1007/s13238-013-0003-2
https://www.ncbi.nlm.nih.gov/pubmed/24474200
https://www.proquest.com/docview/1504151525
https://www.proquest.com/docview/1746897495
https://pubmed.ncbi.nlm.nih.gov/PMC3938852
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9QwEA96hyCI-N89dYngk1JsmzRJn-QsdxyC66G3UJ9CkibuwtLq7Z7gmx_CT-gncab_ZM9jwZdC6aS0mUkyv0zmN4S8sEr6JHEissLyiCdeREYJHlnjuQqiykOOicLvZ-Jkzt-VWdmTRWMuzKX4_es1oCWGx60Y5j-zCGbb_SxhEqs0FKIYt1NixgCJtKVUhOQw78blEMO86i3IpLBo6i_fYH3YWpFuLdrjFb5qj6Fe5Xb-e3ryUgi1XZmO75DbvUtJDzsbuEuu-foeudEVmfxxn-SFX63WtAJT--4rivkkdHn6qaDQqdR6usQMkQbsaOno75-_6Ge_ps05nTVvHpD58dFZcRL1BRMiB0BjEwkLwykPSgKGYBa7GpbrIFVmUsurPObSYgBYhMACc5VUNvWuckYBTA08tuwh2aub2j8m1CiTClOZREkGEEwYgGUu5sE6w5C_ZkIOxg7UXztiDM1zcAcB9E5IPPSodj3VOFa8WOm_JMmoEA0Kweg30-mEvBybDK_bIZxsqUkHJHvA0uG72jwfVKlhBGFYxNS-uYAmGdIUYB2oHTKSCwXQKweZR536x88EB0lymGwmRG4ZxiiADN7bT-rlomXyZjlTKoNvezWYkO6nkB1_cvBf0k_ITfDxeLdr9JTsbc4v_DPwozZ2Sq7LUk7J_tuj2elHuCtSPm1H1bTdmYDr2YcSrvP08A90fhZK
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Ra9swEBajZbRQyra2W7p102BPKwY7UiT5aYzQkm1tGKyF9ElIstQEgt016aBv_RH7hfslu5PtlGwl0OecHEd3Ot2Xu_uOkA9WSZ9lTiRWWJ7wzIvEKMETazxXQRR5yLFR-HQoBuf866g3avq4Z221e5uSjJ76vtmNwfWSxGkEWFAFfnedA2TGOr5-0-IQ3S9jgEniUBUhOXjgdNRmMx96CnIqjKvy8id849LdtDWOhRa-iAWpDwWg_9dR_pNMjXfU8TOy3QSX9HNtDc_JE1--IE_rcZO3OyTv--l0Rgswul--oNhZQifff_QpbC-1nk6wV6QCi5o4-ufuN73wM1pd02H1aZecHx-d9QdJMzohcQA55omwcLDyoCSgCWZx0-HiDlL1TNfyIk-5tJgKFiGwwFwhle16VzijALAGnlq2R9bKqvSvCDXKdIUpTKYkAzAmDAA0l_JgnWHIZNMh-4sN1Fc1RYbmOQSGAH87JG13VLuGdBxnX0z1PV0yKkSDQjAPznS3Qz4ulrSPWyGcLalJB6R9wCHiq9a8b1Wp4SxhgsSUvrqBJT0kLMCJUCtkJBcKQFgOMi9r9S9eE0IlycHtdIhcMoyFAHJ5L39STsaR05vlTKkevNtha0K6cSYrfsn-o6TfkY3B2emJPvky_PaabELkx-v_kt6Qtfn1jT-A6Gpu38bT9Bc1jBbf
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZaxsxEBYloaVQQs_E6aVCn1qW7FqypH0KZVuTXibQBtwnoTM2mN00dgp964_oL-wvycxewW0w9HlHe2hG0nw7M98Q8tIqGbLMicQKyxOeBZEYJXhiTeAqCp_HHAuFP0_E0Qn_MB1N2z6nyy7bvQtJNjUNyNJUrg7OfDy4KnxjcNQkdWcCTK6CPXgbgEqG6KsQRf-TJWUM8EndYEVIDrtxOu0im9fdBfkVZlV5-h2evnZO3ZnVSRfB18mp1zmj_-ZU_hVYrc-r8V2y0zqa9E1jGffIjVDeJzeb1pM_H5C8CIvFknowwB_BU6wyofPjLwWFqaY20DnWjVRgXXNH__z6Tb-FJa3O6aQ6fEhOxu--FkdJ20YhcQA_VomwsMjyqCQgC2ZRAXCIR6lGZmi5z1MuLYaFRYwsMuelssPgvDMKwGvkqWWPyFZZlWGPUKPMUBhvMiUZADNhAKy5lEfrDENWmwHZ7ydQnzV0GZrn4CQCFB6QtJtR7VoCcuyDsdBX1MmoEA0KwZg408MBedUP6W63QThbU5OOSAGBDcU3jXnRqVLDusJgiSlDdQFDRkhegN2hNshILhQAshxkdhv1968JbpPksAUNiFwzjF4Aeb3Xr5TzWc3vzXKm1Aje7XVnQrrdWDZ8yf5_ST8nt47fjvWn95OPj8ltcAJ581vpCdlanV-Ep-BoreyzejFdAmyvG0I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cells+derived+from+iPSC+can+be+immunogenic+-+Yes+or+No%3F&rft.jtitle=Protein+%26+cell&rft.au=Cao%2C+Jiani&rft.au=Li%2C+Xiaoyan&rft.au=Lu%2C+Xiao&rft.au=Zhang%2C+Chao&rft.date=2014&rft.pub=Higher+Education+Press&rft.issn=1674-800X&rft.eissn=1674-8018&rft.volume=5&rft.issue=1&rft.spage=1&rft.epage=3&rft_id=info:doi/10.1007%2Fs13238-013-0003-2&rft.externalDBID=n%2Fa&rft.externalDocID=10.1007%2Fs13238-013-0003-2
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F71234X%2F71234X.jpg